GlassScriptPhysician profile
Jason Cuomo
NPI 1104231232
$1,612.23
in general payments reported to CMS, 2019-2025
16 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $436 · 2020: $273 · 2022: $437 · 2023: $137 · 2024: $159 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $466.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $276.17 | 2022-2025 | Watchman Flx, Watchman Access System, Watchman |
| Ge Healthcare | $267.53 | 2022 | |
| Abiomed | $252.70 | 2019-2020 | |
| Medtronic Vascular, INC. | $245.85 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $127.11 | 2022-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.61 | 2019-2025 | Lifevest |
| Pfizer INC. | $72.49 | 2019-2025 | |
| Cardiva Medical, INC. | $58.11 | 2019 | |
| Heartflow, INC. | $49.57 | 2023-2025 | Ffrct |
| Lexicon Pharmaceuticals, INC. | $35.54 | 2023-2024 | Inpefa |
| Janssen Pharmaceuticals, INC | $28.06 | 2019-2020 | |
| Cvrx, INC. | $26.70 | 2025 | Barostim Neo System |
| Lantheus Medical Imaging, INC. | $26.02 | 2022 | |
| Alnylam Pharmaceuticals INC. | $21.90 | 2023 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $21.88 | 2024 | Camzyos |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $14.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Cuomo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.